PAZZAGLI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 10.437
EU - Europa 6.819
AS - Asia 1.628
OC - Oceania 89
AF - Africa 60
SA - Sud America 40
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.077
Nazione #
US - Stati Uniti d'America 10.416
PL - Polonia 2.396
RU - Federazione Russa 1.674
HK - Hong Kong 658
IT - Italia 636
IE - Irlanda 581
SE - Svezia 541
SG - Singapore 439
UA - Ucraina 286
DE - Germania 220
CN - Cina 191
FI - Finlandia 174
IN - India 108
CH - Svizzera 106
AU - Australia 89
JO - Giordania 87
GB - Regno Unito 82
VN - Vietnam 46
CI - Costa d'Avorio 44
FR - Francia 43
TR - Turchia 41
BR - Brasile 36
ID - Indonesia 29
NL - Olanda 23
CA - Canada 16
ES - Italia 15
AT - Austria 14
BE - Belgio 13
SC - Seychelles 12
KR - Corea 10
BG - Bulgaria 5
EU - Europa 4
AZ - Azerbaigian 3
BD - Bangladesh 3
LK - Sri Lanka 3
AR - Argentina 2
JP - Giappone 2
LV - Lettonia 2
MU - Mauritius 2
RO - Romania 2
TW - Taiwan 2
AL - Albania 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MX - Messico 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 19.077
Città #
Warsaw 2.395
Santa Clara 2.008
Fairfield 1.330
Chandler 655
Woodbridge 643
Ashburn 618
Dublin 580
Seattle 579
Hong Kong 523
Cambridge 522
Wilmington 463
Houston 462
Jacksonville 456
Singapore 263
Ann Arbor 214
Altamura 204
Lawrence 196
Princeton 184
Florence 175
Boardman 128
Boston 113
Bern 98
Buffalo 94
Melbourne 89
San Diego 85
Mumbai 76
Medford 74
Beijing 63
Falls Church 57
Shanghai 52
New York 47
Abidjan 44
Dong Ket 40
Norwalk 40
Izmir 37
Kent 31
Jakarta 29
Los Angeles 29
Bremen 28
Moscow 25
Pune 25
Milan 24
Andover 23
Auburn Hills 22
Helsinki 19
Yubileyny 19
Hillsboro 18
Phoenix 17
Vienna 14
Brussels 12
Frankfurt Am Main 12
Verona 12
West Jordan 12
Redwood City 11
Barcelona 10
Toronto 10
Seoul 9
Bondeno 7
Dearborn 6
Geneva 6
London 6
Old Bridge 6
Redmond 6
Rome 6
Tappahannock 6
Fuzhou 5
Salerno 5
Sofia 5
Turin 5
Brescia 4
Laurel 4
Munich 4
Nanjing 4
Prato 4
Amsterdam 3
Aradeo 3
Baku 3
Bari 3
Capua 3
Chicago 3
Council Bluffs 3
Grosseto 3
Guangzhou 3
New Bedfont 3
Norcross 3
Palermo 3
Predaia - Campodenno 3
Prescot 3
San Mateo 3
Stockholm 3
The Dalles 3
Augusta 2
Belo Horizonte 2
Castelfiorentino 2
Castelliri 2
Centro 2
Chengdu 2
Colombo 2
Dordrecht 2
Fontebuona 2
Totale 14.176
Nome #
Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions 308
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers 306
A high-resolution melting protocol for rapid and accurate differential diagnosis of thyroid nodules. 304
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers 290
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 279
Circulating BRAFV600E in the diagnosis and follow-up of differentiated papillary thyroid carcinoma. 277
Multiparametric analysis of cell-free DNA in melanoma patients. 265
Influence of 17q gain and promoter polymorphisms on mRNA expression of somatostatin receptor type 2 in neuroblastoma. 263
Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay. 252
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. 243
Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. 241
NEW INSIGHTS IN THE CLINICAL AND TRANSLATIONAL RELEVANCE OF miR483-5p IN ADRENOCORTICAL CANCER 241
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 236
SPIDIA-DNA: an External Quality Assessment for the pre-analytical phase of blood samples used for DNA-based analyses. 235
SPIDIA-RNA: second external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. 232
Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics 226
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer 223
Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing 219
null 196
Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma 174
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. 168
Application of a filtration and isolation by size technique for the detection of circulating tumor cells in cutaneous melanoma. 157
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 151
Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method 144
Red or white wine assumption and serum antioxidant capacity. 144
Quantitative RT-PCR assay for VEGF mRNA in human tumors of the kidney. 143
The glycopeptide csf114(glc) detects serum antibodies in multiple sclerosis. 142
DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA: A MONOCENTRIC PRELIMINARY STUDY. 140
Centenarians in Tuscany: The role of the environmental factors. 139
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers 139
Adenosine triphosphate release by osmotic shock and hemoglobin A1C in diabetic subjects' erythrocytes. 136
Implementation of a proficiency testing for the assessment of the preanalytical phase of blood samples used for RNA based analysis. 136
Circulating tumour cells in colorectal cancer 135
The pre-analytical phase of the liquid biopsy 135
Age-related changes in serum total antioxidant capacity (TAC), dehydroepiandrosterone sulphate (DHEAS) and insulin-like growth factor-1 (IGF-1): evidence in healthy centenarian subjects. 135
Circulating cell-free DNA in cancer 134
Urinary carbonic anhydrase IX splicing messenger RNA variants in urogenital cancers 134
luciferase gene as reporter: comparison with CAT gene and use in transfection and microinjection of mammalian cells 132
Real-time PCR detection of Biscogniauxia mediterranea in symptomless oak tissue 132
Combining qualitative and quantitative imaging evaluation for the assessment of genomic DNA integrity: The SPIDIA experience 132
An Italian Program of External Quality Control for Quantitative Assays Based on Real-Time PCR with Taq-Man Probes. 131
Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer. 131
Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome. 131
Glycated hemoglobin (HbA1c) measurement in frozen whole blood depends on baseline values of fresh samples. 131
Allele specific Taqman–based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients. 130
Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue 129
Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. 129
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 129
Measurement of steroids in human plasma and tissues by isotope dilution mass spectrometry. 128
Detection of Diplodia pinea in asymptomatic pine shoots and its relation to the Normalized Insolation index 128
A real-time quantitative PCR assay for the detection of Sphaeropsis sapinea from inoculated Pinus nigra shoots 128
SPIDIA-RNA: First external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. 128
Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. 125
Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide. 124
Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma. 123
Improvement of technical and analytical performance in DNA sequencing by external quality assessment-based molecular training. 122
BRAFV600E detection in melanoma is highlyimproved by COLD-PCR. 122
Healthy centenarian subjects as living model of "successful aging": A study on fasting glycemia, C-peptide, dehydroepiandrosterone sulphate (DHEAS) and insulin-like growth factor (IGF-1). 119
NUCLEOSIDE ANALOGUES AS RADIOSENSITIZERS IN THE TREATMENT OF LUNG CANCER 117
Implementation of a companion diagnostic in the clinical laboratory: The BRAF example in melanoma 117
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe 116
Longevity index (LI%) and centenarity index (CI%): New indicators to evaluate the characteristics of aging process in the Italian population. 116
Comparison of pre- and postsurgical concentrations of blood HER-2 mRNA and HER-2 extracellular domain reflects HER-2 status in early breast cancer. 115
Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. 115
Analysis of 12q13-15 genes in parosteal osteosarcoma 115
Circulating benign nevus cells detected by ISET technique: warning for melanoma molecular diagnosis. 115
Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction. 114
Methodologic European external quality assurance for DNA sequencing: the EQUALseq program. 113
Laser microdissection on Norway spruce bark tissue: A suitable protocol for subsequent real-time reverse transcription–polymerase chain reaction (RT-PCR) analysis 113
Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique 113
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers. 113
Effects of gemcitabine in normal and transformed human lung cell cultures: citotoxicity and increase of radiation sensitivity 113
The meat in the diet of aged subjects and the antioxidant effects of carnosine. 111
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients 111
Evaluation of the liquid biopsy for the detection of brafv600e mutation in metastatic melanoma patients 110
An assay procedure for plasma progesterone based on antibody-enhanced chemiluminescence. 109
Effect of diet and red wine consumption on serum total antioxidant capacity (TAC), dehydroepiandrosterone-sulphate (DHEAS) and insulin-like growth factor-1 (IGF-1) in Italian centenarians. 109
Age-related secretion of androstenedione, testosterone and dihydrotestosterone by the human testis. 107
EQUAL-qual: a European program for external quality assessment of genomic DNA extraction and PCR amplification. 107
Biological parameters for the choice of antiangiogenic therapy and efficacy monitoring 107
A solid phase chemiluminescent immunoassay (LIA) for testosterone glicuronide in diluted urines. 106
Healthy centenarian subjects: the effect of red wine consumption on liver function tests. 106
Telomerase in urological malignancy 103
GENE AMPLIFICATION FOR c-erbB-2, c-myc, epidermal growth factor receptor, int-2 and N-myc MEASURED BY QUANTITATIVE PCR WITH A MULTIPLE COMPETITOR TEMPLATE. 103
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas 101
Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay. 101
Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate. 101
Rapid, quantitative nonisoptopic assay for telomerase activity in human tumors 100
Melting temperature analysis as quantitative method for detection of point mutations. 98
Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction 98
Developments in quantitative PCR. 97
The c-erbB-2 oncogene amplification by competitive PCR in aneuploid cell clones flow sorted from breast cancer samples. 97
Evaluation of different progesterone-isoluminol conjugates for chemiluminescence immunoassay. 97
An immunoassay for plasma cortisol based on chemiluminescence. 97
Laser-assisted microdissection for real-time PCR sample preparation. 97
Image analysis in quantitative PCR. An application for the measurement of c-erbB-2 oncogene amplification in DNA from human tumours. 97
Circulating nucleic acids in cancer and pregnancy 97
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study 96
Statistical diagnostics emerging from external quality control of real-time PCR. 96
Dihydrotestosterone in human spermatic venous plasma. 95
Totale 14.565
Categoria #
all - tutte 50.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020841 0 0 0 0 0 0 0 0 337 180 258 66
2020/20212.185 206 177 122 322 124 270 79 173 188 248 121 155
2021/20221.160 30 80 79 40 77 81 50 60 76 62 198 327
2022/20232.943 295 557 87 253 243 501 349 155 280 18 73 132
2023/2024967 50 119 168 50 61 140 43 196 15 28 66 31
2024/20255.363 199 660 376 1.013 1.868 666 99 424 58 0 0 0
Totale 19.225